BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6184448)

  • 1. Studies on the chemical reactivity of copper bleomycin.
    Antholine WE; Solaiman D; Saryan LA; Petering DH
    J Inorg Biochem; 1982 Oct; 17(2):75-94. PubMed ID: 6184448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of the initial reaction of bleomycin and several of its metal complexes with Ehrlich cells.
    Lyman S; Ujjani B; Renner K; Antholine W; Petering DH; Whetstone JW; Knight JM
    Cancer Res; 1986 Sep; 46(9):4472-8. PubMed ID: 2425953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper(I)-bleomycin: structurally unique complex that mediates oxidative DNA strand scission.
    Ehrenfeld GM; Rodriguez LO; Hecht SM; Chang C; Basus VJ; Oppenheimer NJ
    Biochemistry; 1985 Jan; 24(1):81-92. PubMed ID: 2581602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic and antitumor properties of bleomycin and several of its metal complexes.
    Rao EA; Saryan LA; Antholine WE; Petering DH
    J Med Chem; 1980 Dec; 23(12):1310-8. PubMed ID: 6161253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of reaction of DNA-bound Fe(III)bleomycin with ascorbate: interplay of specific and non-specific binding.
    Li W; Antholine WE; Petering DH
    J Inorg Biochem; 2002 May; 90(1-2):8-17. PubMed ID: 12009250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper(I) . bleomycin. A structurally unique oxidation-reduction active complex.
    Oppenheimer NJ; Chang C; Rodriguez LO; Hecht SM
    J Biol Chem; 1981 Feb; 256(4):1514-7. PubMed ID: 6161924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of the reaction of bleomycin-Fe(II)-O2 complex with DNA.
    Ekimoto H; Kuramochi H; Takahashi K; Matsuda A; Umezawa H
    J Antibiot (Tokyo); 1980 Apr; 33(4):426-34. PubMed ID: 6157664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA strand breakage in isolated nuclei subjected to bleomycin or hydrogen peroxide.
    Byrnes RW; Petering DH
    Biochem Pharmacol; 1994 Aug; 48(3):575-82. PubMed ID: 7520697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature of thiol-compounds which trap cuprous ion reductively liberated from bleomycin-Cu(II) in cells.
    Takahashi K; Takita T; Umezawa H
    J Antibiot (Tokyo); 1987 Mar; 40(3):348-53. PubMed ID: 2437092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular DNA strand scission and growth inhibition of Ehrlich ascites tumor cells by bleomycins.
    Byrnes RW; Templin J; Sem D; Lyman S; Petering DH
    Cancer Res; 1990 Sep; 50(17):5275-86. PubMed ID: 1696848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of bleomycin in iron- and copper-deficient cells.
    Lyman S; Taylor P; Lornitzo F; Wier A; Stone D; Antholine WE; Petering DH
    Biochem Pharmacol; 1989 Dec; 38(23):4273-82. PubMed ID: 2480795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions among iron(II) bleomycin, Lewis bases, and DNA.
    Antholine WE; Petering DH; Saryan LA; Brown CE
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7517-20. PubMed ID: 6174974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orientation of iron bleomycin and porphyrin complexes on DNA fibers.
    Chikira M; Iiyama T; Sakamoto K; Antholine WE; Petering DH
    Inorg Chem; 2000 Apr; 39(8):1779-86. PubMed ID: 12526568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA strand scission by activated bleomycin group antibiotics.
    Hecht SM
    Fed Proc; 1986 Nov; 45(12):2784-91. PubMed ID: 2429877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An active intermediate formed in the reaction of bleomycin-Fe(II) complex with oxygen.
    Kuramochi H; Takahashi K; Takita T; Umezawa H
    J Antibiot (Tokyo); 1981 May; 34(5):576-82. PubMed ID: 6168629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of iron bleomycin, phosphate or cyanide, and DNA: sequence-dependent conformations and reactions.
    Li W; Xia C; Antholine WE; Petering DH
    J Biol Inorg Chem; 2001 Jun; 6(5-6):618-27. PubMed ID: 11472025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of redox-inactivated bleomycins. In vitro DNA damage and inhibition of Ehrlich cell proliferation.
    Templin J; Berry L; Lyman S; Byrnes RW; Antholine WE; Petering DH
    Biochem Pharmacol; 1992 Feb; 43(3):615-23. PubMed ID: 1371685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of cytotoxicity of bleomycin by dithiocarbamates: formation of bis(dithiocarbamato) cu(II).
    Ujjani B; Lyman S; Winkelmann D; Antholine W; Petering DH; Jones MM
    J Inorg Biochem; 1990 Jan; 38(1):81-93. PubMed ID: 1692085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbic acid oxidation and DNA scission catalyzed by iron and copper chelates.
    Aronovitch J; Godinger D; Samuni A; Czapski G
    Free Radic Res Commun; 1987; 2(4-6):241-58. PubMed ID: 2462529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox cycling of bleomycin-Fe(III) and DNA degradation by isolated NADH-cytochrome b5 reductase: involvement of cytochrome b5.
    Mahmutoglu I; Kappus H
    Mol Pharmacol; 1988 Oct; 34(4):578-83. PubMed ID: 2459594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.